advertisement
Eye 32
Showing records 1 to 25 | Display all abstracts in Eye20318 Peripapillary atrophy in elderly Chinese in rural and urban Beijing
Wang Y; Xu L; Zhang L; Yang H; Ma Y; Jonas JB
Eye 2008; 22: 261-266
20582 Glaucoma is a neuronal disease
Caprioli J
Eye 2007; 21: S6-S10
20412 Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects
Foresta C; Caretta N; Zuccarello D; Poletti A; Biagioli A; Caretti L; Galan A
Eye 2008; 22: 144-149
20576 Correlation of visual changes with disc morphology
Garway-Heath DF
Eye 2007; 21: S29-S33
20581 The neurobiology of cell death in glaucoma
Vrabec JP; Levin LA
Eye 2007; 21: S11-S14
20580 DARC: A new method for detecting progressive neuronal death
Cordeiro MF
Eye 2007; 21: S15-S17
20826 Prevalence of serum autoantibodies and paraproteins in patients with glaucoma
Hammam T; Montgomery D; Morris D; Imrie F
Eye 2008; 22: 349-353
20583 Update on the natural history of glaucoma
Hitchings R
Eye 2007; 21: S2-S5
20577 Correlating nerve fibre layer defects spatially with functional loss
Schiefer U; Paetzold J; Krapp E; Nevalainen J; Besch D
Eye 2007; 21: S25-S28
20579 High-resolution imaging of retinal cells in the living eye
Paques M; Simonutti M; Roux MJ; Bellman C; Lacombe F; Grieve K; Glanc M; LeMer Y; Sahel J-A
Eye 2007; 21: S18-S20
20382 Performance of GDx VCC in eyes with peripapillary atrophy: comparison of three circle sizes
Kunimatsu S; Tomidokoro A; Saito H; Aihara M; Tomita G; Araie M
Eye 2008; 22: 173-178
20832 Stratus-OCT imaging in early glaucomatous and in ocular hypertensive patients with and without frequency-doubling technology abnormalities
Brusini P; Zeppieri M; Tosoni C; Parisi L; Felletti M; Salvetat ML
Eye 2008; 22: 406-413
20835 Optical coherence tomography in a patient with tobacco-alcohol amblyopia
Kee C; Hwang JM
Eye 2008; 22: 469-470
20417 The spectrum of iris angiography abnormalities in pseudoexfoliation syndrome
Parodi MB; Liberali T; Iacono P; Nicola MD; Ballone E; Ravalico G
Eye 2008; 22: 49-54
20843 First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label study
Gherghel D; Hosking SL; Cunliffe IA; Armstrong RA
Eye 2008; 22: 363-369
20816 Does an iridotomy provide protection against narrowing of the anterior chamber angle during Valsalva maneuvre in eyes with primary angle closure
Sihota R; Dada T; Aggarwal A; Srinivasan G; Gupta V; Chabra VK
Eye 2008; 22: 389-393
20416 Prospective, long-term evaluation of steroid-induced glaucoma
Sihota R; Konkal VL; Dada T; Agarwal HC; Singh R
Eye 2008; 22: 26-30
20413 Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome
Yaǧcı R; Ersöz I; Erdurmuş M; Gürel A; Duman S
Eye 2008; 22: 128-131
20414 Hospital Episode Statistics and changing trends in glaucoma surgery
Fraser SG; Wormald RP
Eye 2008; 22: 3-7
20317 A review of glaucoma treatment in Scotland 1994-2004
Macleod SM; Clark R; Forrest J; Bain M; Bateman N; Azuara-Blanco A
Eye 2008; 22: 251-255
20834 Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course
Izzotti A; Saccà SC; Di Marco B; Penco S; Bassi AM
Eye 2008; 22: 445-453
20312 The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension
Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
Eye 2008; 22: 179-183
20573 Neuroprotection of retinal ganglion cell function and their central nervous system targets
Vidal-Sanz M; de la Villa P; Aviles-Trigueros M; Mayor-Torroglosa S; Salinas-Navarro M; Alarcon-Martinez L; Villegas-Perez MP
Eye 2007; 21: S42-S45
20572 A clinical trial studying neuroprotection in low-pressure glaucoma
Krupin T
Eye 2007; 21: S51-S54
20574 Detecting the effects of neuroprotection in living cells
Funk RHW; Kniep E-M; Rohlecke C
Eye 2007; 21: S38-S41
